JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


JAOA • Vol 104 • No 6 • June 2004 • 240-243
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Folio, C. L. R.
Right arrow Articles by Younker, M. M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Folio, C. L. R.
Right arrow Articles by Younker, M. M. R.

ORIGINAL CONTRIBUTION

Initial Experience With Mass Immunization as a Bioterrorism Countermeasure

Col Les R. Folio, DO, USAF; Maj Ronald L. Lahti, USAF; Maj David S. Cockrum, MD, USAF; Maj Steven Bills, USAF; Maj Michael R. Younker, DO, USAF

From the David Grant Medical Center, Travis Air Force Base, Calif (Folio, Lahti, Bills, Younker) and Fairchild Air Force Base, Wash (Cockrum).

Address correspondence to Col Les Folio, DO, USAF, Science Technology Division, Headquarters United States Air Force, Three Skyline Place, 5201 Leesburg Pike, Ste 1400, Falls Church, VA 22041-3203.

Anthrax vaccine was administered to approximately 5000 individuals at a deployed location near Iraq in a 1-week period. This report describes the planning and administrative process to initiate such a program, with a snapshot view of the first week of immunization. Compliance with this program was important to best protect troops in this high-threat region. The authors share their experience and detail the process of handling refusals, as these are most likely to reveal themselves at the beginning of an immunization program. The program resulted in a compliance rate of 98%. With increased terrorist threats and widespread availability of biologic agents of mass destruction, experiences with such immunization programs should be described in the literature and analyzed in anticipation of similar programs in the future.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Osteopathic Association.